跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
CANESORAL COMBI 1 DAY - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
CANESORAL COMBI 1 DAY
Authorized
STANDARD
CANESORAL COMBI 1 DAY
Bayer Inc
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
068e7a72ac9c52ac
Company
Bayer Inc
Type
Standard
Approval Details
Approval Id
068e7a72ac9c52ac
Drug Approval Canada Name
CANESORAL COMBI 1 DAY
Product Name
CANESORAL COMBI 1 DAY
Status
Marketed
Status Date
2020-02-14
Original Market Date
2020-02-14
Din
02490935
Drug Class
Human
Dosage Form
Capsule , Cream
Route Of Administration
Oral , Topical
Schedule
OTC
Aig Number
0252465002
Company Name
Bayer Inc
Company Address
2920 Matheson Blvd East, Mississauga, Ontario, Canada, L4W 5R6
Active Ingredients
CLOTRIMAZOLE
2 % / W/W
FLUCONAZOLE
150 MG / CAP
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
068e7a72ac9c52ac
Type
Standard
Back to Health Canada Approvals